Cholesterol medication recalled over ‘failed dissolution specifications’: What to know
(NEXSTAR) – Over 141,000 bottles of cholesterol medication have been recalled due to “failed dissolution specifications,” suggesting that…
More than 140,000 bottles of cholesterol medication part of elevated recall over health risk
A major recall of thousands of bottles of medication has been upgraded to a higher risk level. In…
Researchers say dangerous ‘Benadryl Challenge’ still active on TikTok
The “Benadryl challenge,” which started in 2020 on TikTok, is still active on social media platforms, despite the…
GLP-1 Weight-Loss Pills Could Transform Treatment
A new era of weight-loss treatment could soon trade needles for pills. Drugmakers behind GLP-1 injections like Wegovy…
Apple Watch Adds FDA-Approved Blood Pressure Alerts Using AI
This article first appeared on GuruFocus. Apple (AAPL, Financials) is adding a new health feature to its Watch…
Do NAD and Peptides Work? The Anti-Aging Injection of the Moment
Like many men his age, William Stern was tired. At 45, the husband, father of three, and founder…
FDA Crackdown Flags Oprah Video and Drug Ad With Morgan Freeman
US regulators issued a flurry of letters calling out pharmaceutical companies for allegedly misleading ads, part of a…
Under Trump, FDA seeks to abandon expert reviews of new drugs
FDA leaders under President Trump are moving to abandon a decades-old policy of asking outside experts to review…
Apple Watch Hypertension Detection Coming Next Week After FDA Nod
Apple Inc. said its hypertension detection system for its smart watch will arrive next week after receiving clearance…
LSD shows promise for reducing anxiety in drugmaker’s midstage study
WASHINGTON (AP) — LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for…
Afraid of Needles? Here’s How to Skip the Shot and Give Yourself a Flu Vaccine at Home
NEED TO KNOW With flu season on the horizon a needle-free way to take the vaccine is now…
BioXcel Therapeutics Announces Positive FDA Pre-sNDA Meeting Comments for sNDA Submission for BXCL501 in Agitation Associated with Bipolar Disorders or Schizophrenia
BioXcel Therapeutics Achieved alignment with the FDA on sNDA package to expand the IGALMI label for the At-Home…